Search for Clinical Trial Results

Chronic Inflammatory Demyelinating Polyneuropathy - 26 Studies Found
Status | Study |
Completed |
Study Name: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2013-04-01 Interventions: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Completed |
Study Name: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2011-06-16 |
Completed |
Study Name: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-08-18 Interventions: Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen |
Withdrawn |
Study Name: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-11-05 Interventions: Drug: Cyclophosphamide |
Active, not recruiting |
Study Name: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2006-01-16 Interventions: Biological: hematopoietic stem cell transplantation Autologous hematopoietic stem cell transplantation |
Completed |
Study Name: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Condition:
Interventions: Drug: lipoic acid Subjects will be started on a single daily dose of 600 mg of alpha lipoic acid or plac |
Completed |
Study Name: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Condition:
|
Active, not recruiting |
Study Name: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition:
|
Recruiting |
Study Name: Subcutaneous Immunoglobulin for CIDP Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2014-12-12 Interventions: Drug: Immune Globulin Subcutaneous (Human) Patients who have CIDP and are on IVIG will be allowed in the |
Recruiting |
Study Name: IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2015-03-13 Interventions: Drug: Intravenous Immunoglobulin The decision to treat with IVIg will be entirely at the discretion of t |